Research
Clinical Evidence
Insufficient-data confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
This compound exhibits an estimated pKa of 7.69, indicating a predominantly neutral character under typical formulation conditions.
Safety
Safety Profile
While a GHS classification under OSHA HCS found no specific hazard or precautionary statements, general safety precautions are advised during handling due to potential health risks if the compound is ingested or inhaled. Its safety for dermal application in cosmetic formulations has not been reviewed by regulatory bodies such as CIR.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to a comprehensive lack of data concerning its mechanism of action, clinical efficacy, and dermatological safety, Phenylacetaldehyde Oxime is not recommended for use in precision skincare formulations at this time.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources